Atricure, Inc. Form 8-K Summary
Business Context and Reporting Period
Atricure, Inc. filed this Current Report on Form 8-K on October 29, 2013, to announce its financial results for the third quarter ended September 30, 2013. The company is incorporated in Delaware and maintains its principal executive offices in West Chester, Ohio.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this Form 8-K.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that third-quarter results have been issued and a conference call was held to discuss them.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in this filing. The document directs investors to the press release (Exhibit 99.1) and the conference call held on October 29, 2013, at 4:30 p.m. Eastern Time for these discussions. The filing explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review the press release attached as Exhibit 99.1 for specific third-quarter financial figures.
- Verify the details of the conference call held on October 29, 2013, for management commentary and guidance.
- Confirm that the financial data in the press release is not considered "filed" under Section 18 of the Exchange Act as noted in the disclaimer.